Alentis and PinotBio Announce Collaboration to Develop Next-Generation ADCs Targeting claudin-1

·1h ago
Share:PostShare

BASEL, Switzerland & SUWON, South Korea--(BUSINESS WIRE)--Under the agreement, Alentis and PinotBio will discover and develop next-generation antibody-drug conjugates targeting claudin-1 for oncology.

B

Businesswire

Original source

Read full story

Related Stories

Health13h ago

CATalyst Council Reports Cat Clinical Visits Grow 2.7 Percent as U.S. Veterinary Clinical Visits Fall 1.9 Percent

NORTH CANTON, Ohio--(BUSINESS WIRE)--Feline clinical visits at U.S. veterinary practices grew 2.7 percent year-over-year in the third quarter of 2026, while canine clinical visits fell 3.3 percent, according to Vetsource data reported in CATalyst Council Feline Veterinary Market Insights: Volume VII. Feline clinical visits grew in each of the last twelve quarters, and canine clinical visits fell in eleven of them. Clinical visits are defined as a patient receiving medical care, including both w

BBusinesswire
Health7h ago

Pope Leo admitted to hospital for operation to remove growth on lung

Leo arrived at hospital on Tuesday for the surgery, which is deemed low risk and could take place this afternoon Pope Leo has been admitted to hospital in Rome for an operation to remove a small growth from his lung, a discovery a top Vatican cardinal said had come “like a bolt out of the blue”. In a rare moment of Vatican transparency, Leo, 71, said during his angelus prayer on Sunday that doctors had found a small nodule on his lung during a check-up, adding that it was “well-contained” and detected early. Continue reading...

TThe Guardian

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer